Dengue is a common mosquito-borne, with high morbidity Background: rates recorded in the annually. Dengue contributes a major disease burden in many tropical countries. This demonstrates the urgent need in developing effective approaches to identify severe cases early. For this purpose, many multivariable prognostic models using multiple prognostic variables were developed to predict the risk of progression to severe outcomes. The aim of the planned systematic review is to identify and describe the existing clinical multivariable prognostic models for severe dengue as well as examine the possibility of combining them. These findings will suggest directions for further research of this field.
Introduction
Dengue is the most common mosquito-borne viral infection globally and a considerable public health burden in many tropical countries 1 . The number of dengue infection has increased rapidly within the past two decades, and it is estimated that the incidence of dengue went up six-fold from 1990 to 2013 2 . Although only a small proportion of dengue-infected patients develop severe dengue, it is responsible for an average of over 9,000 deaths per year over the same time period 2 . The current WHO's guidelines suggests 2 levels of severity: dengue with/without warning signs and severe dengue 3 . While the former is usually a mild illness with considerable morbidity but low mortality, the latter is associated with uncompensated plasma leakage which may lead to hypovolemic shock, organ dysfunction and several complications including death 4 . Disease management is mainly based on early supportive treatment, since there is no specific antiviral drugs available [4] [5] [6] . Therefore, identifying early patients who are at risk of developing severe outcomes based on simple and readily available risk factors plays an important role in dengue case management. Potential predictors could be ranged from clinical features and standard laboratory tests, including hematocrit and platelet count to viral and immunological markers as well as novel markers of endothelial activation and vascular functions 7 . To accurately evaluate the risks of a specific clinical outcome for individual patients, a single predictor is hardly adequate, hence, there is a need to develop a multivariable prognostic model using multiple prognostic variables 8 . Building a prediction model, which comprises three typical elements including suggested predictors, an outcome and a statistical model, is the third step of a 4-step recommended design for prognostic research 9 .
Recently, many clinical prognostic studies for severe dengue have been published. However, there remains no widely accepted paradigm to predict disease severity. This may be due to the heterogeneity in the study populations and design, clinical definitions of "severe" dengue, candidate predictors and analytical approaches between studies. It is therefore necessary to conduct this systematic review to provide a general and detailed description of the status quo of clinical prediction models for severe dengue, and to suggest further development in this emerging field of research.
Research aims
The primary aim of this systematic review is to identify and evaluate currently available multivariable prognostic models for severe dengue. To the authors' knowledge, this is the first time that multivariable prognostic models for severe dengue have been reviewed systematically. The secondary purpose is to establish if there is any possibility to combine these models. Furthermore, some suggestions will be given on how to develop robust and applicable clinical prediction models for severe dengue.
Methods
This protocol has been prepared using the Preferred Reporting Items for Systematic Reviews and Meta -Analyses Protocol (PRISMA-P) 10 . The PRISMA-P checklist available as part of the Reporting guidelines 11 .
Selection criteria Study design. We will include all published articles on developing, validating or updating the multivariable prognostic models aiming to predict the risk of death or severe dengue based on the WHO 1997 and 2009 dengue case classification. There is no restriction on language, time of publication, country in which the study was conducted or study setting. Book chapters, commentaries, conference abstract, reviews, editorials, guidelines and letters will be excluded. We will take into consideration all types of prognostic model development studies (e.g. with or without external validation in independent data, and with or without model updating).
Primary and secondary outcomes
The primary outcomes of this systematic review will be the number of current available clinical multivariable prognostic models for severe dengue and their properties including: study designs, outcomes, candidate predictors, statistical approach, validation status, and model performance. The secondary outcome of this systematic review is the possibility to combine these identified models into a more comprehensive prediction model. Since the patient characteristics are broad, to build up the search strategy, we will focus our keywords on two main parts:
Search strategy
(1) "prognostic model" for clinical multivariable prognostic model, and (2) "severe dengue" for outcome relating to DHF, DSS of the WHO 1997, severe dengue of the WHO 2009 dengue case classification and mortality. The search strategies will be designed by combining index terms and text words relating to two main parts mentioned. All possible synonyms of these terms will be identified and included to cover more comprehensively the review subject. We will use Boolean operator "OR" to link all index terms, text words and synonyms into particular groups relating to main keywords and Boolean operator "AND" to link all groups into the final search string. Search fields will be applied to make the search string more appropriate to each database. We will only focus on the articles relating to human subjects. The Boolean operator "NOT" will be also used to exclude book chapters, documents, editorials, review and guidelines. There is no restriction on language and publication date. The sample search strategy developed for PubMed, Embase and Web of Science as Extended data 11 .
Selection of studies Study selection will be conducted by following the PRISMA flow diagram. We will capture the reference lists from each database and then import them into Mendeley software to remove duplications. The BibTex file containing all filtered references will be then exported. We will import the BibTex file into JabRef software to create the Excel file as the reference list. The recorded data will be managed by the reference lists throughout the review process. Two independent reviewers will screen simultaneously all titles and abstracts based on the following broad screening criteria: (1) focusing on human subjects, (2) focusing on developing the clinical prognostic model, (3) focusing on severe dengue outcome (DHF, DSS of the 1997 WHO dengue case classification and Severe Dengue of 2009 WHO dengue case classification, and mortality). We will exclude articles that do not meet the screening criteria above. Any discrepancies reported during the study screening will be resolved through discussion with a third reviewer. Full-texts of identified abstracts will be retrieved and reviewed to check for more detailed criteria:
(1) focusing on developing a multivariable model relating to severe dengue, (2) focusing on patients who were diagnosed with dengue infection based on clinical features and/or dengue diagnostic test. Identified publication will be excluded if full-text is not available. If any disagreements occur, we will reach a consensus by consulting a third reviewer. The reasons for excluding the articles will be reported in detail. Attempts will be made to translate the non-English articles into English.
Data extraction
Extracting data will be performed by two independent reviewers to collect essential data from full texts. The form for extracting data will be designed based on the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS . All data retrieved from identified full-texts will be imported into the in-depth form. Any discrepancy will be resolved by discussing with the third reviewer to reach a consensus.
We will extract the following data as a minimum:
• Article information: author, year of publication, country of publication, location
• Source of data: study design (e.g. prospective or retrospective, case -control, etc) , follow-up time, study context (in primary or secondary health care center)
• Participants: patient characteristics, for example age, gender, dengue diagnosis criteria, comorbidity, given treatment, etc. recruitment method, number of study centers, patient inclusion and exclusion criteria.
• • Model applicability and interpretation: strengths, limitations and applicability in clinical setting
Assessment of study quality All identified studies meeting the eligible criteria will be assessed based on the domains suggested by Prediction study Risk Of Bias Assessment Tool (PROBAST), the current recommended tool for assessing the risk of bias in prognostic studies 16 . This tool was built up by experts in the field on the basis of the Delphi process comprising five domains: participant selection, predictors, outcome, sample size, and participant flow and analysis, with detailed guidance for determining potential items that could possibly be biased 16 . The quality of identified studies will be evaluated by two independent reviewers. Discrepancies will be resolved by discussing with the third reviewer.
Data synthesis
We will descriptively analyze all clinical multivariable prognostic models by describing and narratively synthesizing the article and model information. No formal meta -analysis will be conducted to summarize the model performance across identified articles. The percentage and frequency of each item will be summarized and tabulated. Each model will be narratively synthesized in terms of sample size, candidate predictors, development method, performance and evaluation, presentation, applicability in clinical practice and risk of bias. From the retrieved information, we will describe the clinical heterogeneities in study participants, candidate predictors, outcomes as well as the methodological heterogeneities in the sources of data, missing data, and statistical approaches. If data on measures of association and predictive performance is insufficient, we will estimate this data using the approaches suggested by Cochrane Collaboration and Parmar et al. 17, 18 . We will also explore the possibility of combining identified prediction models into a more comprehensive model using a recent meta-analysis approach 19 . The trend in the development of prognostic models for severe dengue from the identified publications throughout years will be reported to make suggestions for further research in this field.
Dissemination of information
Our research findings will be presented at scientific conferences and published in peer-reviewed scientific journals. We will also disseminate the findings on popular science newspapers.
Study status
The publication search has been completed. Currently, we are conducting screening identified publications.
Discussion
The early and proper identification of patients who are at risk of severe dengue requires processing inputs from a variety of clinical signs, examination results, and epidemiological characteristics. While clinicians may find it challenging and overwhelming to utilize such a volume of information, prediction models can help as handy tools to support in monitoring, decision making and treating dengue patients. Given the emerging prediction models in dengue infection and heterogeneous characteristics of models and algorithms, we hope this review will provide a systematic evaluation of the existing literature in the field. From our review, recommendations could be made on how to develop and report prediction models for severe dengue, how to use these models and where to focus for research in the field in near future.
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12. Various prognostic models may have used various variables, how do authors think to compare the different situational/regional/global models with each other since every region/situation cannot be comparable.
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Are sufficient details of the methods provided to allow replication by others? Yes
Are the datasets clearly presented in a useable and accessible format? Partly
No competing interests were disclosed.
Competing Interests:
Reviewer Expertise: disease prognostic models, process based models, dengue fever transmission models I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
countries over the world. To clarify that, we have modified the sentence to: "it is responsible for an average of over 9,000 deaths per year over the same time period, globally." 4. After mentioning the rate of dengue, the severity of dengue has been stated all of a sudden. It requires mentioning more information beforehand regarding the severity of dengue fever. Authors should consider maintaining a rhythm of the topic of concern. We have added this sentence to briefly mention about dengue severity after the sentence about global rate of dengue: ""The disease has a wide-spectrum of clinical manifestations, from self-limited mild illness to severe dengue [reference: Simmons (2012) ]"" et al.
5
. Introduction section should be revised considerably to inform the background of the intended study. As presented in our protocol, the introduction is divided into 3 main parts, namely: 1/ Global epidemiology of dengue -Paragraph 1: line 1 -line 14 2/ Difficulties of dengue management and the importance in early predicting severe dengue progression -Paragraph 2: line 15 -line 30 3/ Limitations of clinical prognostic studies -objectives of systematic review Unless there is any specific background information you suggest that we should add, we believe that this structure and the presented introduction section provide adequate and appropriate information as background of our study.
6. The objective of the study does not clearly mention whether the study intends to identify the severe dengue within an individual patient or is it a collective term for a severe dengue incidence within a region? As mentioned in our protocol, our objective is to describe in detail the status of existing clinical prediction models, mainly focusing on prognosis, for predicting risk of severe dengue progression, and to suggest possible development for this field of research. . https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564751/ 7. Authors should describe the term "multivariate prognostic". Of note, we did not use the term "multivariate prognostic" but rather the term "multivariable prognostic models" in our manuscript (we believe that statistically, there are major differences between these two terms, "multivariable" and "multivariate"). "Multivariable prognostic models" refers to prognostic models which are multivariable, which in turn is a standard term that refers to statistical regression models with more than one predictor (independent variables) (Reference: Hidalgo B and Goodman M (2013) Multivariate or Multivariable Regression?. Am J Public Health, 103(1):39-40).
Authors should revise the methods section and eliminate repetition in the text.
We have checked the methods section multiple times for repetition. Even though there are some words/phrases look similar to each other, they are actually different and refer to different things. Therefore, we still keep this section as it currently stands.
Authors may consider introducing any such multivariate prognostic models, if they exist.
We have introduced a recent such model in the first sentence of the fourth paragraph in the In the second paragraph of the manuscript, we already briefly mentioned about considered prognostic variables of severe dengue: "Potential predictors could be ranged from clinical features and standard laboratory tests, including hematocrit and platelet count to viral and immunological markers as well as novel markers of endothelial activation and vascular functions". Transmission of dengue plays an important role in dengue diagnosis and public health intervention; however, "transmission of severe dengue" seems not to be very relevant to our study. Even though there is some evidence to suggest that specific dengue serotype (especially serotype DENV-2) is more associated with severe dengue than other serotypes [Simmons C (2012) Dengue. et al. NEJM, 366(15):1423-32], severe dengue is rather a consequence of a complex interaction between viral and host factors than a separated entity which can be transmitted.
11. As authors stated that "there remains no widely accepted paradigm to predict disease severity…" how do authors defend carrying out this study based on the various global disease predictive models which are not well-designed/functional? Why and how this study would be useful and applicable in reality for policy making or treatment. The fact that "there remains no widely accepted paradigm to predict disease …" does not mean that current predictive models in the field are "not well-designed/functional". We believe that this fact generally means two things: (1) the topic is still an open field for research and exploration, and (2) a high heterogeneity in how research is conducted and reported is expected. High heterogeneity in research design and report makes it extremely difficult to aggregate research findings in order to draw overall conclusions or develop a care management policy that is applicable. For this reason, we conduct this systematic review to identify this heterogeneity by detailed describing of published research and carefully assess their quality. Our findings would then be the basis for further attempts to harmonize and standardize how prognostic models for severe dengue are developed and reported. Together with other similar movements (such as the CONSORT statement for reporting randomized controlled trials), this piece of research would be one of the important factors to maintain and improve the quality of research as well as facilitate research progress in this field.
12. Various prognostic models may have used various variables, how do authors think to compare the different situational/regional/global models with each other since every region/situation cannot be comparable Heterogeneity in included predictors is a big issue for any attempt to compare or combine different prognostic models. In terms of comparison, we acknowledge this heterogeneity and thus focus more on comparing study designs, methods for model development and model presentation. In terms of combination, we will first explore the possibility to combine published models using approaches described in Debray (2014) Metaanalysis and aggregation of multiple published et al. prediction models. Statistics in Medicine, 33(14):2341-62, namely "model averaging" and "staked regressions", which allow combining models with different sets of predictors.
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